Rich Vincent

Rich Vincent is the Chief Financial Officer of Medcura. Rich previously held senior management positions at Meritage Pharma, Sorrento Therapeutics, Elevation Pharmaceuticals, Verus Pharmaceuticals, Women First HealthCare, Elan Pharmaceuticals, Phase Metrics, and Deloitte & Touche LLP, where he specialized in emerging growth and publicly-traded companies. Over the past 20+ years, Rich’s experience includes raising over 50 million through venture capital, major commercial banks and institutions, public offering proceeds for high growth pharmaceutical and technology-based companies, and participating in a number of acquisitions and divestitures valued at over billion. Rich was named 2014 public company CFO of the Year in San Diego by the San Diego Business Journal.